Webinar: AI, Regulation and the Legislation: Shaping the Way forward for Drug Improvement
On this dialogue, our friends discover how current regulatory adjustments are shaping the way forward for AI in drug improvement within the US market. We may even focus on the ripple impact these adjustments are having on a worldwide scale. Our friends will present their insights from investor, regulatory and authorized views to unpack the most recent adjustments to steerage and communications their impacts on market and improvement methods, cross-border collaboration, and authorized frameworks.
Key Subjects:
- Latest regulatory updates on AI in healthcare and drug improvement
- Implications for cross-border collaboration and U.S.–European alignment
- Judicial and compliance traits shaping the way forward for AI innovation
- Methods for bringing AI options to market below evolving rules
Panelists
Register to look at
